Drugs / QPX2014
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05072444 | Nov 2021 | bacterial infectious disease | Qpex Biopharma, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT04380207 | Nov 2020 → Aug 2022 | bacterial infectious disease | Qpex Biopharma, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QPX2014 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05072444 ↗ |